News
Results were announced from a phase 3 trial evaluating solriamfetol for major depressive disorder with/without severe excessive daytime sleepiness.
4d
News-Medical.Net on MSNLithium shifts circadian rhythms early in bipolar disorder and may offer clues to treatment responseA randomized controlled trial shows that lithium treatment in bipolar disorder patients reduces daytime activity, advances ...
Bright Minds Biosciences has a decent balance sheet, with roughly $40.3 million in cash. Click here to find out why I rate ...
When it comes to women’s health, there are many topics that aren’t discussed as often as they should be — or discussed ...
April 2025 presents Scorpio with a transformative month, emphasizing resolution of past complications, strategic career ...
The We Defy Foundation is celebrating 10 years of fulfilling their mission of providing therapeutic relief for disabled ...
The largest planned development in the area is the mixed-use Village Center project ... sense of awareness of what’s going on ...
Could a small investment change your summer plans? Certain cryptocurrencies under a dollar may hold the key to making a ...
8d
Cryptopolitan on MSNDOGE Price on the Brink: Analysts See Drop Below $0.10 in June as XYZVerse (XYZ) Poised to Capture 80% of Crypto Holders by 2026Dogecoin may be heading towards a sharp price drop, with analysts forecasting it could slip below ten cents in June due to ...
Midjourney v7 shows improvements in creativity and natural language understanding, but it doesn't beat v6 across all tests.
Ethereum's price has fallen 65% in three months, with technical indicators suggesting a bottom near $1,000 as the market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results